Could this mRNA vaccine stop the virus behind mono and certain cancers?
⭐️ VACCINE ⭐️
Not yet recruiting
This early-stage study tests a new mRNA vaccine called VXCO-102 in 45 healthy young adults aged 18 to 25. The goal is to see if the vaccine is safe and triggers an immune response against Epstein-Barr virus (EBV), which causes mononucleosis and is linked to some cancers. Particip…
Phase: PHASE1 • Sponsor: Vaccine Company, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 08:48 UTC